507
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Dysfunctional HDL: the journey from savior to slayer

, , , &
Pages 49-59 | Published online: 18 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria-Corina Serban, Maciej Banach & Dimitri P Mikhailidis. (2016) Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options. Expert Opinion on Pharmacotherapy 17:3, pages 369-380.
Read now

Articles from other publishers (11)

Rohan Dod, Aishwarya Rajendran, Mayuri Kathrotia, Amanda Clarke & Sunita Dodani. (2022) Cardiovascular Disease in South Asian Immigrants: a Review of Dysfunctional HDL as a Potential Marker. Journal of Racial and Ethnic Health Disparities 10:3, pages 1194-1200.
Crossref
Ipek Ertorun, Gülşen Akalın Çiftçi & İ. Özkan Alataş. (2022) High-density lipoprotein: Quality is more important than quantity!. European Journal of Life Sciences 1:1, pages 35-41.
Crossref
Efosa Godwin Ewere, Ngozi Paulinus Okolie, Erhunmwunsee Dalton Avan & Patience Edet Umoh. (2021) Comparative effects of ethanol leaf and stem bark extracts of Irvingia gabonensis (BUSH MANGO) on sodium arsenite-induced lipid profile perturbtions in wistar rats. Clinical Phytoscience 7:1.
Crossref
Arianna Bonizzi, Gabriele Piuri, Fabio Corsi, Roberta Cazzola & Serena Mazzucchelli. (2021) HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity. Biomedicines 9:7, pages 729.
Crossref
Peter E. Penson & Maciej Banach. (2021) Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes. Atherosclerosis 316, pages 58-65.
Crossref
Peter P. Toth. (2019) Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should we Reach Beyond LDL-C?. Current Vascular Pharmacology 17:4, pages 376-378.
Crossref
Kyung-Hyun ChoKyung-Hyun Cho. 2019. High-Density Lipoproteins as Biomarkers and Therapeutic Tools. High-Density Lipoproteins as Biomarkers and Therapeutic Tools 115 261 .
Nicholas J. Woudberg, Sarah Pedretti, Sandrine Lecour, Rainer Schulz, Nicolas Vuilleumier, Richard W. James & Miguel A. Frias. (2018) Pharmacological Intervention to Modulate HDL: What Do We Target?. Frontiers in Pharmacology 8.
Crossref
Maciej Banach, Wilbert S. Aronow, Corina Serban, Amirhossein Sahabkar, Jacek Rysz, Luminita Voroneanu & Adrian Covic. (2015) Lipids, blood pressure and kidney update 2014. Pharmacological Research 95-96, pages 111-125.
Crossref
Seth S. Martin, Steven R. Jones & Peter P. Toth. (2014) High-density lipoprotein subfractions: current views and clinical practice applications. Trends in Endocrinology & Metabolism 25:7, pages 329-336.
Crossref
Piotr Chrusciel, Jacek Rysz & Maciej Banach. (2014) Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease. Drugs 74:9, pages 971-980.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.